{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T10:48:06Z","timestamp":1782730086352,"version":"3.54.5"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006507","name":"Funda\u00e7\u00e3o Oswaldo Cruz","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006507","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Parasit."],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s11686-026-01269-2","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T08:56:51Z","timestamp":1778662611000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nitazoxanide Exhibits Schistosomicidal Activity Against Schistosomula and Adult Schistosoma mansoni and Influences Praziquantel-Associated Outcomes"],"prefix":"10.1007","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9922-6565","authenticated-orcid":false,"given":"C\u00edcero J\u00e1dson","family":"Da Costa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2991-9024","authenticated-orcid":false,"given":"Juliana Ellen de Melo","family":"Gama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4314-9134","authenticated-orcid":false,"given":"Alex Jos\u00e9 de Melo","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3492-7467","authenticated-orcid":false,"given":"Karina Lidianne Alc\u00e2ntara","family":"Saraiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7008-5930","authenticated-orcid":false,"given":"Christina Alves","family":"Peixoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roni Ev\u00eancio","family":"de Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Andr\u00e9 Laranjeira Miranda","family":"Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4222-390X","authenticated-orcid":false,"given":"Gustavo Henrique Aires","family":"Albuquerque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9158-9724","authenticated-orcid":false,"given":"Danielle Maria Nascimento","family":"Moura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4759-8436","authenticated-orcid":false,"given":"Sheilla Andrade","family":"De Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"issue":"1","key":"1269_CR1","doi-asserted-by":"publisher","first-page":"49","DOI":"10.5603\/imh.99453","volume":"75","author":"YH Condeng","year":"2024","unstructured":"Condeng YH, Katu S, Aman AM, Rasyid H, Bakri S, Iskandar H (2024) Praziquantel as the preferred treatment for schistosomiasis. Int Marit Health 75(1):49\u201354. https:\/\/doi.org\/10.5603\/imh.99453","journal-title":"Int Marit Health"},{"issue":"19","key":"1269_CR2","doi-asserted-by":"publisher","first-page":"6807","DOI":"10.3390\/molecules28196807","volume":"28","author":"CM Azevedo","year":"2023","unstructured":"Azevedo CM, Meira CS, Da Silva JW et al (2023) Therapeutic potential of natural products in the treatment of schistosomiasis. Molecules 28(19):6807. https:\/\/doi.org\/10.3390\/molecules28196807","journal-title":"Molecules"},{"issue":"1","key":"1269_CR3","doi-asserted-by":"publisher","first-page":"e0010687","DOI":"10.1371\/journal.pntd.0010687","volume":"17","author":"L Mujumbusi","year":"2023","unstructured":"Mujumbusi L, Nalwadda E, Ssali A et al (2023) Understanding perceptions of schistosomiasis and its control among highly endemic lakeshore communities in Mayuge, Uganda. PLoS Negl Trop Dis 17(1):e0010687. https:\/\/doi.org\/10.1371\/journal.pntd.0010687","journal-title":"PLoS Negl Trop Dis"},{"issue":"11","key":"1269_CR4","doi-asserted-by":"publisher","first-page":"e327","DOI":"10.1016\/S1473-3099(22)00221-3","volume":"22","author":"NC Lo","year":"2022","unstructured":"Lo NC, Bezerra FSM, Colley DG et al (2022) Review of 2022 WHO guidelines on the control and elimination of schistosomiasis. Lancet Infect Dis 22(11):e327\u2013e335. https:\/\/doi.org\/10.1016\/S1473-3099(22)00221-3","journal-title":"Lancet Infect Dis"},{"key":"1269_CR5","doi-asserted-by":"crossref","unstructured":"Berry A, Fillaux J, Martin-Blondel G et al (2016) Evidence for a permanent presence of schistosomiasis in Corsica, France, 2015. Euro Surveill 21(1).","DOI":"10.2807\/1560-7917.ES.2016.21.1.30100"},{"issue":"7","key":"1269_CR6","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.ijpara.2005.02.005","volume":"35","author":"S Botros","year":"2005","unstructured":"Botros S, Sayed H, Amer N, El-Ghannam M, Bennett JL, Day TA (2005) Current status of sensitivity to praziquantel in a focus of potential drug resistance in Egypt. Int J Parasitol 35(7):787\u2013791. https:\/\/doi.org\/10.1016\/j.ijpara.2005.02.005","journal-title":"Int J Parasitol"},{"key":"1269_CR7","doi-asserted-by":"publisher","unstructured":"Summers S, Bhattacharyya T, Allan F et al (2022) A review of the genetic determinants of praziquantel resistance in Schistosoma mansoni: is praziquantel and intestinal schistosomiasis a perfect match? 3:933097. Frontiers in Tropical Diseaseshttps:\/\/doi.org\/10.3389\/fitd.2022.933097","DOI":"10.3389\/fitd.2022.933097"},{"issue":"3","key":"1269_CR8","doi-asserted-by":"publisher","first-page":"e0009200","DOI":"10.1371\/journal.pntd.0009200","volume":"15","author":"P McCusker","year":"2021","unstructured":"McCusker P, Rohr CM, Chan JD (2021) Schistosoma mansoni alter transcription of immunomodulatory gene products following in vivo praziquantel exposure. PLoS Negl Trop Dis 15(3):e0009200. https:\/\/doi.org\/10.1371\/journal.pntd.0009200","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"1269_CR9","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1093\/infdis\/151.6.1130","volume":"151","author":"SH Xiao","year":"1985","unstructured":"Xiao SH, Catto BA, Webster LT Jr (1985) Effects of praziquantel on different developmental stages of Schistosoma mansoni in vitro and in vivo. J Infect Dis 151(6):1130\u20131137. https:\/\/doi.org\/10.1093\/infdis\/151.6.1130","journal-title":"J Infect Dis"},{"issue":"2","key":"1269_CR10","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/BF00389899","volume":"52","author":"R G\u00f6nnert","year":"1977","unstructured":"G\u00f6nnert R, Andrews P (1977) Praziquantel, a new board-spectrum antischistosomal agent. Z fur Parasitenkunde (Berlin Germany) 52(2):129\u2013150. https:\/\/doi.org\/10.1007\/BF00389899","journal-title":"Z fur Parasitenkunde (Berlin Germany)"},{"issue":"9","key":"1269_CR11","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1039\/c9md00298g","volume":"10","author":"EOJ Porta","year":"2019","unstructured":"Porta EOJ, Bofill Verdaguer I, Perez C et al (2019) Repositioning Salirasib as a new antimalarial agent. MedChemComm 10(9):1599\u20131605. https:\/\/doi.org\/10.1039\/c9md00298g","journal-title":"MedChemComm"},{"issue":"1","key":"1269_CR12","doi-asserted-by":"publisher","first-page":"e0007481","DOI":"10.1371\/journal.pntd.0007481","volume":"14","author":"M Say\u00e9","year":"2020","unstructured":"Say\u00e9 M, Gauna L, Valera-Vera E, Reigada C, Miranda MR, Pereira CA (2020) Crystal violet structural analogues identified by in silico drug repositioning present anti-Trypanosoma cruzi activity through inhibition of proline transporter TcAAAP069. PLoS Negl Trop Dis 14(1):e0007481. https:\/\/doi.org\/10.1371\/journal.pntd.0007481","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"1269_CR13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s00436-023-08062-4","volume":"123","author":"MM Corvi","year":"2023","unstructured":"Corvi MM, Rossi F, Ganuza A et al (2023) Triclabendazole and clofazimine reduce replication and spermine uptake in vitro in Toxoplasma gondii. Parasitol Res 123(1):69. https:\/\/doi.org\/10.1007\/s00436-023-08062-4","journal-title":"Parasitol Res"},{"issue":"2","key":"1269_CR14","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1093\/cid\/ciaa1482","volume":"73","author":"PY Iroh Tam","year":"2021","unstructured":"Iroh Tam PY, Arnold SLM, Barrett LK et al (2021) Clofazimine for treatment of cryptosporidiosis in HIV-infected adults: an experimental medicine randomized placebo-controlled phase 2a trial. Clin Infect Dis 73(2):183\u2013191. https:\/\/doi.org\/10.1093\/cid\/ciaa1482","journal-title":"Clin Infect Dis"},{"issue":"1","key":"1269_CR15","doi-asserted-by":"publisher","first-page":"e0156021","DOI":"10.1128\/AAC.01560-21","volume":"66","author":"CX Zhang","year":"2022","unstructured":"Zhang CX, Love MS, McNamara CW et al (2022) Pharmacokinetics and Pharmacodynamics of Clofazimine for Treatment of Cryptosporidiosis. Antimicrob Agents Chemother 66(1):e0156021. https:\/\/doi.org\/10.1128\/AAC.01560-21","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"1269_CR16","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1111\/cas.13540","volume":"109","author":"X Xu","year":"2018","unstructured":"Xu X, Wang J, Han K, Li S, Xu F, Yang Y (2018) Antimalarial drug mefloquine inhibits nuclear factor kappa B signaling and induces apoptosis in colorectal cancer cells. Cancer Sci 109(4):1220\u20131229. https:\/\/doi.org\/10.1111\/cas.13540","journal-title":"Cancer Sci"},{"issue":"11","key":"1269_CR17","doi-asserted-by":"publisher","first-page":"e0028422","DOI":"10.1128\/aac.00284-22","volume":"66","author":"RP Pandey","year":"2022","unstructured":"Pandey RP, Nascimento MS, Franco CH et al (2022) Drug Repurposing in Chagas Disease: Chloroquine Potentiates Benznidazole Activity against Trypanosoma cruzi In Vitro and In Vivo. Antimicrob Agents Chemother 66(11):e0028422. https:\/\/doi.org\/10.1128\/aac.00284-22","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"1269_CR18","doi-asserted-by":"publisher","first-page":"101084","DOI":"10.1016\/j.jpha.2024.101084","volume":"15","author":"S Hu","year":"2025","unstructured":"Hu S, Batool Z, Zheng X, Yang Y, Ullah A, Shen B (2025) Exploration of innovative drug repurposing strategies for combating human protozoan diseases: Advances, challenges, and opportunities. J Pharm Anal 15(1):101084. https:\/\/doi.org\/10.1016\/j.jpha.2024.101084","journal-title":"J Pharm Anal"},{"issue":"4","key":"1269_CR19","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.3390\/molecules27041414","volume":"27","author":"B Pereira Moreira","year":"2022","unstructured":"Pereira Moreira B, Weber MHW, Haeberlein S, Mokosch AS, Spengler B, Grevelding CG, Falcone FH (2022) Drug Repurposing and De Novo Drug Discovery of Protein Kinase Inhibitors as New Drugs against Schistosomiasis. Molecules 27(4):1414. https:\/\/doi.org\/10.3390\/molecules27041414","journal-title":"Molecules"},{"issue":"3","key":"1269_CR20","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s00436-024-08168-3","volume":"123","author":"Y Yuan","year":"2024","unstructured":"Yuan Y, Zhao Q, Suo X, Liu X, Hao Z (2024) Anthelmintic efficacy of nitazoxanide in dogs naturally infected with Toxocara canis. Parasitol Res 123(3):162. https:\/\/doi.org\/10.1007\/s00436-024-08168-3","journal-title":"Parasitol Res"},{"issue":"7","key":"1269_CR21","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1002\/cpdd.1402","volume":"13","author":"C Zhang","year":"2024","unstructured":"Zhang C, Liang R, Liu D et al (2024) Pharmacokinetics of Nitazoxanide Dry Suspensions After Single Oral Doses in Healthy Subjects: Food Effects Evaluation and Bioequivalence Study. Clin Pharmacol drug Dev 13(7):748\u2013754. https:\/\/doi.org\/10.1002\/cpdd.1402","journal-title":"Clin Pharmacol drug Dev"},{"issue":"4","key":"1269_CR22","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1007\/s11686-021-00385-5","volume":"66","author":"A \u00c1ngeles-Arvizu","year":"2021","unstructured":"\u00c1ngeles-Arvizu A, Enriquez-Flores S, Jim\u00e9nez-Guti\u00e9rrez A et al (2021) MDR1 protein (ABC-C1) Over Expression in Giardia Intestinalis Incubated with Albendazole and Nitazoxanide. Acta Parasitol 66(4):1158\u20131166. https:\/\/doi.org\/10.1007\/s11686-021-00385-5","journal-title":"Acta Parasitol"},{"issue":"7","key":"1269_CR23","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1358\/dot.2021.57.7.3235211","volume":"57","author":"C Bharti","year":"2021","unstructured":"Bharti C, Sharma S, Goswami N, Sharma H, Rabbani SA, Kumar S (2021) Role of nitazoxanide as a repurposed drug in the treatment and management of various diseases. Drugs today (Barcelona Spain: 1998) 57(7):455\u2013473. https:\/\/doi.org\/10.1358\/dot.2021.57.7.3235211","journal-title":"Drugs today (Barcelona Spain: 1998)"},{"key":"1269_CR24","unstructured":"Brasil (2012) Minist\u00e9rio da Sa\u00fade. Consultoria Jur\u00eddica\/Advocacia Geral da Uni\u00e3o. Nota T\u00e9cnica n\u00b0 167\/2012 [Technical Note No. 167\/2012]. Bras\u00edlia, Brazil (in Portuguese)"},{"issue":"1","key":"1269_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.molbiopara.2013.12.002","volume":"193","author":"VS Somvanshi","year":"2014","unstructured":"Somvanshi VS, Ellis BL, Hu Y, Aroian RV (2014) Nitazoxanide: nematicidal mode of action and drug combination studies. Mol Biochem Parasitol 193(1):1\u20138. https:\/\/doi.org\/10.1016\/j.molbiopara.2013.12.002","journal-title":"Mol Biochem Parasitol"},{"key":"1269_CR26","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.antiviral.2014.07.014","volume":"110","author":"JF Rossignol","year":"2014","unstructured":"Rossignol JF (2014) Nitazoxanide: a first-in-class broad-spectrum antiviral agent. Antiviral Res 110:94\u2013103. https:\/\/doi.org\/10.1016\/j.antiviral.2014.07.014","journal-title":"Antiviral Res"},{"issue":"11","key":"1269_CR27","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1021\/ml200157f","volume":"2","author":"LP De Carvalho","year":"2011","unstructured":"De Carvalho LP, Darby CM, Rhee KY, Nathan C (2011) Nitazoxanide Disrupts Membrane Potential and Intrabacterial pH Homeostasis of Mycobacterium tuberculosis. ACS Med Chem Lett 2(11):849\u2013854. https:\/\/doi.org\/10.1021\/ml200157f","journal-title":"ACS Med Chem Lett"},{"issue":"10","key":"1269_CR28","doi-asserted-by":"publisher","first-page":"4504","DOI":"10.3390\/ijms26104504","volume":"26","author":"L Morales-Luna","year":"2025","unstructured":"Morales-Luna L, Hern\u00e1ndez-Ochoa B, Gonz\u00e1lez-Valdez A et al (2025) Nitazoxanide Analogs: Synthesis, In Vitro Giardicidal Activity, and Effects on Giardia lamblia Metabolic Gene Expression. Int J Mol Sci 26(10):4504. https:\/\/doi.org\/10.3390\/ijms26104504. Published 2025 May 8","journal-title":"Int J Mol Sci"},{"issue":"7","key":"1269_CR29","doi-asserted-by":"publisher","first-page":"e0271724","DOI":"10.1128\/spectrum.02717-24","volume":"13","author":"KJ Graves","year":"2025","unstructured":"Graves KJ, Williamson JC, Novak J, Tiwari HK, Secor WE, Muzny CA (2025) Nitazoxanide and tizoxanide demonstrate high levels of in vitro activity against metronidazole-susceptible and metronidazole-resistant Trichomonas vaginalis clinical isolates. Microbiol Spectr 13(7):e0271724. https:\/\/doi.org\/10.1128\/spectrum.02717-24","journal-title":"Microbiol Spectr"},{"issue":"1","key":"1269_CR30","doi-asserted-by":"publisher","first-page":"4813","DOI":"10.1038\/s41467-024-48807-y","volume":"15","author":"Z Cui","year":"2024","unstructured":"Cui Z, Liu J, Xie C et al (2024) High-throughput screening unveils nitazoxanide as a potent PRRSV inhibitor by targeting NMRAL1. Nat Commun 15(1):4813. https:\/\/doi.org\/10.1038\/s41467-024-48807-y","journal-title":"Nat Commun"},{"issue":"14","key":"1269_CR31","doi-asserted-by":"publisher","first-page":"11516","DOI":"10.3390\/ijms241411516","volume":"24","author":"V Mart\u00ednez-Rosas","year":"2023","unstructured":"Mart\u00ednez-Rosas V, Hern\u00e1ndez-Ochoa B, Morales-Luna L et al (2023) Nitazoxanide Inhibits the Bifunctional Enzyme GlG6PD:6PGL of Giardia lamblia: Biochemical and In Silico Characterization of a New Druggable Target. Int J Mol Sci 24(14):11516. https:\/\/doi.org\/10.3390\/ijms241411516","journal-title":"Int J Mol Sci"},{"key":"1269_CR32","doi-asserted-by":"publisher","first-page":"104148","DOI":"10.1016\/j.ebiom.2022.104148","volume":"82","author":"JS Driouich","year":"2022","unstructured":"Driouich JS, Cochin M, Touret F et al (2022) Pre-clinical evaluation of antiviral activity of nitazoxanide against SARS-CoV-2. EBioMedicine 82:104148. https:\/\/doi.org\/10.1016\/j.ebiom.2022.104148","journal-title":"EBioMedicine"},{"issue":"11","key":"1269_CR33","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1007\/s00436-017-5614-8","volume":"116","author":"JM Nasareth","year":"2017","unstructured":"Nasareth JM, Fraga CM, Lima NF et al (2017) vivo treatment with nitazoxanide induces anaerobic metabolism in experimental intraperitoneal cysticercosis. Parasitol Res 116(11):3037\u20133041. https:\/\/doi.org\/10.1007\/s00436-017-5614-8","journal-title":"Parasitol Res"},{"issue":"2","key":"1269_CR34","doi-asserted-by":"publisher","first-page":"228","DOI":"10.14419\/ijpt.v4i2.6822","volume":"4","author":"HA El-Taweel","year":"2016","unstructured":"El-Taweel HA, El-Sayad MH, Abou-Holw SA, Alkazzaz MA (2016) Comparative parasitological and electron microscopic studies on the effects of nitazoxanide and praziquantel in Schistosoma mansoni-infected mice. Int J Pharmacol Toxicol 4(2):228\u2013234. https:\/\/doi.org\/10.14419\/ijpt.v4i2.6822","journal-title":"Int J Pharmacol Toxicol"},{"issue":"12","key":"1269_CR35","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.3390\/biom11121817","volume":"11","author":"M Castillo-Salazar","year":"2021","unstructured":"Castillo-Salazar M, S\u00e1nchez-Mu\u00f1oz F, Del Springall R et al (2021) Nitazoxanide Exerts Immunomodulatory Effects on Peripheral Blood Mononuclear Cells from Type 2 Diabetes Patients. Biomolecules 11(12):1817. https:\/\/doi.org\/10.3390\/biom11121817","journal-title":"Biomolecules"},{"issue":"6","key":"1269_CR36","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1128\/am.20.6.919-926.1970","volume":"20","author":"PM Allen","year":"1970","unstructured":"Allen PM, Gottlieb D (1970) Mechanism of action of the fungicide thiabendazole, 2-(4\u2019-thiazolyl) benzimidazole. Appl Microbiol 20(6):919\u2013926. https:\/\/doi.org\/10.1128\/am.20.6.919-926.1970","journal-title":"Appl Microbiol"},{"issue":"3\u20134","key":"1269_CR37","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0304-4017(87)90048-3","volume":"24","author":"P Tejada","year":"1987","unstructured":"Tejada P, Sanchez-Moreno M, Monteoliva M, Gomez-Banqueri H (1987) Inhibition of malate dehydrogenase enzymes by benzimidazole anthelmintics. Vet Parasitol 24(3\u20134):269\u2013274. https:\/\/doi.org\/10.1016\/0304-4017(87)90048-3","journal-title":"Vet Parasitol"},{"issue":"4","key":"1269_CR38","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/0169-4758(90)90227-u","volume":"6","author":"E Lacey","year":"1990","unstructured":"Lacey E (1990) Mode of action of benzimidazoles. Parasitol today (Personal ed) 6(4):112\u2013115. https:\/\/doi.org\/10.1016\/0169-4758(90)90227-u","journal-title":"Parasitol today (Personal ed)"},{"issue":"6","key":"1269_CR39","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.3390\/molecules29061218","volume":"29","author":"S Bai","year":"2024","unstructured":"Bai S, Zhang M, Tang S et al (2024) Research Progress on Benzimidazole Fungicides: A Review. Molecules 29(6):1218. https:\/\/doi.org\/10.3390\/molecules29061218","journal-title":"Molecules"},{"key":"1269_CR40","doi-asserted-by":"publisher","first-page":"123516","DOI":"10.1016\/j.ijpharm.2023.123516","volume":"647","author":"L Aeindartehran","year":"2023","unstructured":"Aeindartehran L, Lefton JB, Burleson J, Unruh DK, Run\u010devski T (2023) Soluble thiabendazolium salts with anthelminthic properties. Int J Pharm 647:123516. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.123516","journal-title":"Int J Pharm"},{"key":"1269_CR41","doi-asserted-by":"publisher","first-page":"130558","DOI":"10.1016\/j.jhazmat.2022.130558","volume":"445","author":"P Han","year":"2023","unstructured":"Han P, Rios-Miguel AB, Tang X et al (2023) Benzimidazole fungicide biotransformation by comammox Nitrospira bacteria: Transformation pathways and associated proteomic responses. J Hazard Mater 445:130558. https:\/\/doi.org\/10.1016\/j.jhazmat.2022.130558","journal-title":"J Hazard Mater"},{"issue":"2","key":"1269_CR42","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1515\/acve-2017-0013","volume":"67","author":"M Abongwa","year":"2017","unstructured":"Abongwa M, Martin RJ, Robertson AP (2017) A brief review on the mode of action of antinematodal drugs. Acta Vet 67(2):137\u2013152. https:\/\/doi.org\/10.1515\/acve-2017-0013","journal-title":"Acta Vet"},{"issue":"8","key":"1269_CR43","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1094\/PHYTO-08-15-0186-R","volume":"106","author":"Y Zhou","year":"2016","unstructured":"Zhou Y, Xu J, Zhu Y, Duan Y, Zhou M (2016) Mechanism of Action of the Benzimidazole Fungicide on Fusarium graminearum: Interfering with Polymerization of Monomeric Tubulin But Not Polymerized Microtubule. Phytopathology 106(8):807\u2013813. https:\/\/doi.org\/10.1094\/PHYTO-08-15-0186-R","journal-title":"Phytopathology"},{"issue":"8","key":"1269_CR44","doi-asserted-by":"publisher","first-page":"e1001379","DOI":"10.1371\/journal.pbio.1001379","volume":"10","author":"HJ Cha","year":"2012","unstructured":"Cha HJ, Byrom M, Mead PE, Ellington AD, Wallingford JB, Marcotte EM (2012) Evolutionarily repurposed networks reveal the well-known antifungal drug thiabendazole to be a novel vascular disrupting agent. PLoS Biol 10(8):e1001379. https:\/\/doi.org\/10.1371\/journal.pbio.1001379","journal-title":"PLoS Biol"},{"issue":"7","key":"1269_CR45","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.pt.2012.04.003","volume":"28","author":"RJ Martin","year":"2012","unstructured":"Martin RJ, Robertson AP, Buxton SK, Beech RN, Charvet CL, Neveu C (2012) Levamisole receptors: a second awakening. Trends Parasitol 28(7):289\u2013296. https:\/\/doi.org\/10.1016\/j.pt.2012.04.003","journal-title":"Trends Parasitol"},{"issue":"1","key":"1269_CR46","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/s0022-4804(03)00053-2","volume":"111","author":"EA Wiebke","year":"2003","unstructured":"Wiebke EA, Grieshop NA, Loehrer PJ, Eckert GJ, Sidner RA (2003) Antitumor effects of 5-fluorouracil on human colon cancer cell lines: antagonism by levamisole. J Surg Res 111(1):63\u201369. https:\/\/doi.org\/10.1016\/s0022-4804(03)00053-2","journal-title":"J Surg Res"},{"issue":"14","key":"1269_CR47","doi-asserted-by":"publisher","first-page":"4957","DOI":"10.3390\/ijms21144957","volume":"21","author":"F Laudisi","year":"2020","unstructured":"Laudisi F, Mar\u00f4nek M, Di Grazia A, Monteleone G, Stolfi C (2020) Repositioning of Anthelmintic Drugs for the Treatment of Cancers of the Digestive System. Int J Mol Sci 21(14):4957. https:\/\/doi.org\/10.3390\/ijms21144957","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1269_CR48","doi-asserted-by":"publisher","first-page":"54","DOI":"10.20398\/jscr.v10i2.18782","volume":"10","author":"AL Costa","year":"2019","unstructured":"Costa AL, Celani LMS, Azevedo \u00cdM, Medeiros AC (2019) Levamisole in treatment of urethane-induced pulmonary carcinoma in rats. J Surg Clin Res 10(2):54\u201364. https:\/\/doi.org\/10.20398\/jscr.v10i2.18782","journal-title":"J Surg Clin Res"},{"key":"1269_CR49","doi-asserted-by":"publisher","first-page":"118034","DOI":"10.1016\/j.lfs.2020.118034","volume":"257","author":"X Qiao","year":"2020","unstructured":"Qiao X, Wang C, Wang W et al (2020) Levamisole enhances DR4-independent apoptosis induced by TRAIL through inhibiting the activation of JNK in lung cancer. Life Sci 257:118034. https:\/\/doi.org\/10.1016\/j.lfs.2020.118034","journal-title":"Life Sci"},{"issue":"9","key":"1269_CR50","doi-asserted-by":"publisher","first-page":"e6234","DOI":"10.5812\/hepatmon.6234","volume":"12","author":"B Sayad","year":"2012","unstructured":"Sayad B, Alavian SM, Najafi F et al (2012) Effects of Oral Levamisole as an Adjuvant to Hepatitis B Vaccine in HIV\/ AIDS Patients: A Randomized Controlled Trial. Hepat monthly 12(9):e6234. https:\/\/doi.org\/10.5812\/hepatmon.6234","journal-title":"Hepat monthly"},{"issue":"4","key":"1269_CR51","doi-asserted-by":"publisher","first-page":"620","DOI":"10.5455\/javar.2023.j717","volume":"10","author":"MH Gholami","year":"2023","unstructured":"Gholami MH, Rassouli A, Mirzaei S, Hashemi F (2023) The potential immunomodulatory effect of levamisole in humans and farm animals. J Adv veterinary Anim Res 10(4):620\u2013629. https:\/\/doi.org\/10.5455\/javar.2023.j717","journal-title":"J Adv veterinary Anim Res"},{"issue":"2","key":"1269_CR52","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/FTD.0000000000000851","volume":"43","author":"KM Midthun","year":"2021","unstructured":"Midthun KM, Nelson LS, Logan BK (2021) Levamisole-a Toxic Adulterant in Illicit Drug Preparations: a Review. Ther Drug Monit 43(2):221\u2013228. https:\/\/doi.org\/10.1097\/FTD.0000000000000851","journal-title":"Ther Drug Monit"},{"issue":"1","key":"1269_CR53","doi-asserted-by":"publisher","first-page":"e0006590","DOI":"10.1371\/journal.pntd.0006590","volume":"13","author":"S Frahm","year":"2019","unstructured":"Frahm S, Anisuzzaman A, Prodjinotho UF, Vejzagi\u0107 N, Verschoor A, Prazeres da Costa C (2019) A novel cell-free method to culture Schistosoma mansoni from cercariae to juvenile worm stages for in vitro drug testing. PLoS Negl Trop Dis 13(1):e0006590. https:\/\/doi.org\/10.1371\/journal.pntd.0006590","journal-title":"PLoS Negl Trop Dis"},{"key":"1269_CR54","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40364-016-0075-2","volume":"4","author":"EM Tekwu","year":"2016","unstructured":"Tekwu EM, Anyan WK, Boamah D et al (2016) Mechanically produced schistosomula as a higher-throughput tools for phenotypic pre-screening in drug sensitivity assays: current research and future trends. Biomark Res 4:21. https:\/\/doi.org\/10.1186\/s40364-016-0075-2","journal-title":"Biomark Res"},{"issue":"7","key":"1269_CR55","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1007\/s00436-018-5897-4","volume":"117","author":"SA De Oliveira","year":"2018","unstructured":"De Oliveira SA, de Oliveira Barbosa M, Filho CALM et al (2018) Phthalimido-thiazole as privileged scaffold: Activity against immature and adult worms of Schistosoma mansoni. Parasitol Res 117(7):2105\u20132115. https:\/\/doi.org\/10.1007\/s00436-018-5897-4","journal-title":"Parasitol Res"},{"key":"1269_CR56","doi-asserted-by":"publisher","DOI":"10.1201\/b17377","volume-title":"Laboratory mouse procedural techniques: Manual and DVD","author":"JJ Bogdanske","year":"2010","unstructured":"Bogdanske JJ, Hubbard GB, Kersey JH et al (2010) Laboratory mouse procedural techniques: Manual and DVD. CRC, Boca Raton"},{"key":"1269_CR57","doi-asserted-by":"crossref","unstructured":"Smith SM, Ribble D, Goldstein NB, Norris DA, Shellman YG (2012) Chapter 20 - A simple technique for quantifying apoptosis in 96-well plates. In Conn, M. P. Methods in Cell Biology 112: 361\u2013368","DOI":"10.1016\/B978-0-12-405914-6.00020-2"},{"key":"1269_CR58","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ejps.2019.03.008","volume":"133","author":"M De Oliveira Barbosa","year":"2019","unstructured":"De Oliveira Barbosa M, de Oliveira SA, Filho CALM et al (2019) Schistosomicidal and prophylactic activities of phthalimido-thiazole derivatives on schistosomula and adult worms. Eur J Pharm Sci 133:15\u201327. https:\/\/doi.org\/10.1016\/j.ejps.2019.03.008","journal-title":"Eur J Pharm Sci"},{"key":"1269_CR59","first-page":"283","volume":"9","author":"WA Hoffman","year":"1934","unstructured":"Hoffman WA, Pons JA, Janer SL (1934) The sedimentation concentration method in Schistosomiasis mansoni. P R J Public Health 9:283\u2013291","journal-title":"P R J Public Health"},{"issue":"2","key":"1269_CR60","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-0105.177703","volume":"7","author":"AB Nair","year":"2016","unstructured":"Nair AB, Jacob S (2016) A simple practice guide for dose conversion between animals and human. J basic Clin Pharm 7(2):27\u201331. https:\/\/doi.org\/10.4103\/0976-0105.177703","journal-title":"J basic Clin Pharm"},{"key":"1269_CR61","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1007\/s00436-022-07533-4","volume":"121","author":"M de Oliveira Barbosa","year":"2022","unstructured":"Laranjeira Miranda Filho CA, de Oliveira Barbosa M, Rodrigues Oliveira A et al (2022) The prophylactic and anti-fibrotic activity of phthalimido-thiazole derivatives in schistosomiasis mansoni. Parasitol Res 121:2111\u20132120. https:\/\/doi.org\/10.1007\/s00436-022-07533-4","journal-title":"Parasitol Res"},{"key":"1269_CR62","doi-asserted-by":"publisher","first-page":"363","DOI":"10.4269\/ajtmh.1965.14.363","volume":"14","author":"J Pellegrino","year":"1965","unstructured":"Pellegrino J, Faria J (1965) The oogram method for the screening of drugs in Schistosomiasis mansoni. Am J Trop Med Hyg 14:363\u2013369. https:\/\/doi.org\/10.4269\/ajtmh.1965.14.363","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"1269_CR63","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/cid\/ciab906","volume":"75","author":"JT Campillo","year":"2022","unstructured":"Campillo JT, Bikita P, Hemilembolo M et al (2022) Safety and efficacy of levamisole in loiasis: A randomized, placebo-controlled, double-blind clinical trial. Clin Infect Dis 75(1):19\u201327. https:\/\/doi.org\/10.1093\/cid\/ciab906","journal-title":"Clin Infect Dis"},{"issue":"7","key":"1269_CR64","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1021\/acsinfecdis.5c00340","volume":"11","author":"T Karpstein","year":"2025","unstructured":"Karpstein T, Kalamatianou A, Keller S et al (2025) Synthesis and Multidisciplinary Preclinical Investigations of Ferrocenyl, Ruthenocenyl, and Benzyl Derivatives of Thiabendazole as New Drug Candidates against Soil-Transmitted Helminth Infections. ACS Infect Dis 11(7):2037\u20132047. https:\/\/doi.org\/10.1021\/acsinfecdis.5c00340","journal-title":"ACS Infect Dis"},{"key":"1269_CR65","doi-asserted-by":"publisher","first-page":"4221","DOI":"10.1007\/s00436-013-3614-x","volume":"112","author":"SA El Bialy","year":"2013","unstructured":"El Bialy SA, Taman A, El-Beshbishi SN et al (2013) Effect of a novel benzimidazole derivative in experimental Schistosoma mansoni infection. Parasitol Res 112:4221\u20134229. https:\/\/doi.org\/10.1007\/s00436-013-3614-x","journal-title":"Parasitol Res"},{"issue":"5","key":"1269_CR66","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1021\/acsinfecdis.0c00278","volume":"7","author":"A Probst","year":"2021","unstructured":"Probst A, Chisanga K, Dziwornu GA, Haeberli C, Keiser J, Chibale K (2021) Expanding the Activity Profile of Pyrido[1,2-a]benzimidazoles: Synthesis and Evaluation of Novel N1-1-Phenylethanamine Derivatives against Schistosoma mansoni. ACS Infect Dis 7(5):1032\u20131043. https:\/\/doi.org\/10.1021\/acsinfecdis.0c00278","journal-title":"ACS Infect Dis"},{"issue":"4","key":"1269_CR67","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1080\/14787210.2022.1990042","volume":"20","author":"S Biendl","year":"2022","unstructured":"Biendl S, H\u00e4berli C, Keiser J (2022) Discovery of novel antischistosomal scaffolds from the open access pandemic response box. Expert Rev Anti Infect Ther 20(4):621\u2013629. https:\/\/doi.org\/10.1080\/14787210.2022.1990042","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"8","key":"1269_CR68","doi-asserted-by":"publisher","first-page":"387","DOI":"10.5414\/cpp38387","volume":"38","author":"J Broekhuysen","year":"2000","unstructured":"Broekhuysen J, Stockis A, Lins RL, De Graeve J, Rossignol JF (2000) Nitazoxanide: pharmacokinetics and metabolism in man. Int J Clin Pharmacol Ther 38(8):387\u2013394. https:\/\/doi.org\/10.5414\/cpp38387","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"5","key":"1269_CR69","doi-asserted-by":"publisher","first-page":"213","DOI":"10.5414\/cpp40213","volume":"40","author":"A Stockis","year":"2002","unstructured":"Stockis A, Allemon AM, De Bruyn S, Gengler C (2002) Nitazoxanide pharmacokinetics and tolerability in man using single ascending oral doses. Int J Clin Pharmacol Ther 40(5):213\u2013220. https:\/\/doi.org\/10.5414\/cpp40213","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"8","key":"1269_CR70","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1080\/17512433.2022.2113388","volume":"15","author":"T Wattanakul","year":"2022","unstructured":"Wattanakul T, Chotsiri P, Scandale I, Hoglund RM, Tarning J (2022) A pharmacometric approach to evaluate drugs for potential repurposing as COVID-19 therapeutics. Expert Rev Clin Pharmacol 15(8):945\u2013958. https:\/\/doi.org\/10.1080\/17512433.2022.2113388","journal-title":"Expert Rev Clin Pharmacol"},{"key":"1269_CR71","doi-asserted-by":"publisher","first-page":"105236","DOI":"10.1016\/j.ejps.2020.105236","volume":"146","author":"CALM Filho","year":"2020","unstructured":"Filho CALM, Barbosa MO, Oliveira AR et al (2020) In vitro and in vivo activities of multi-target phthalimido-thiazoles on Schistosomiasis mansoni. Eur J Pharm Sci 146:105236. https:\/\/doi.org\/10.1016\/j.ejps.2020.105236","journal-title":"Eur J Pharm Sci"},{"key":"1269_CR72","volume-title":"WHO guideline on control and elimination of human schistosomiasis","author":"World Health Organization","year":"2022","unstructured":"World Health Organization (2022) WHO guideline on control and elimination of human schistosomiasis. World Health Organization, Geneva. https:\/\/www.who.int\/publications\/i\/item\/9789240041608"},{"issue":"1","key":"1269_CR73","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s41182-023-00562-4","volume":"51","author":"T Tadele","year":"2023","unstructured":"Tadele T, Astatkie A, Tadesse BT, Makonnen E, Aklillu E, Abay SM (2023) Efficacy and safety of praziquantel treatment against Schistosoma mansoni infection among pre-school age children in southern Ethiopia. Trop Med health 51(1):72. https:\/\/doi.org\/10.1186\/s41182-023-00562-4","journal-title":"Trop Med health"},{"issue":"2","key":"1269_CR74","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/S2055-6640(20)30017-0","volume":"6","author":"T Pepperrell","year":"2020","unstructured":"Pepperrell T, Pilkington V, Owen A, Wang J, Hill AM (2020) Review of safety and minimum pricing of nitazoxanide for potential treatment of COVID-19. J virus eradication 6(2):52\u201360. https:\/\/doi.org\/10.1016\/S2055-6640(20)30017-0","journal-title":"J virus eradication"},{"issue":"11","key":"1269_CR75","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1007\/s00228-022-03380-5","volume":"78","author":"PR Martins-Filho","year":"2022","unstructured":"Martins-Filho PR, do Nascimento-J\u00fanior EM, Barreto-Alves JA, Fakhouri R, Ferreira LC (2022) Efficacy and safety of nitazoxanide in treating SARS-CoV-2 infection: a systematic review and meta-analysis of blinded, placebo-controlled, randomized clinical trials. Eur J Clin Pharmacol 78(11):1813\u20131821. https:\/\/doi.org\/10.1007\/s00228-022-03380-5","journal-title":"Eur J Clin Pharmacol"},{"issue":"7","key":"1269_CR76","doi-asserted-by":"publisher","first-page":"e70702","DOI":"10.1371\/journal.pone.0070702","volume":"8","author":"Y Hu","year":"2013","unstructured":"Hu Y, Ellis BL, Yiu YY et al (2013) An extensive comparison of the effect of anthelmintic classes on diverse nematodes. PLoS ONE 8(7):e70702. https:\/\/doi.org\/10.1371\/journal.pone.0070702","journal-title":"PLoS ONE"}],"container-title":["Acta Parasitologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11686-026-01269-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11686-026-01269-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11686-026-01269-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T10:25:49Z","timestamp":1782728749000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11686-026-01269-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":76,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1269"],"URL":"https:\/\/doi.org\/10.1007\/s11686-026-01269-2","relation":{},"ISSN":["1230-2821","1896-1851"],"issn-type":[{"value":"1230-2821","type":"print"},{"value":"1896-1851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"assertion":[{"value":"11 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal experiments were carried out in accordance with the Brazilian National Council for the Control of Animal Experimentation (CONCEA) guidelines. Experimental protocols were approved by the Institutional Animal Care and Use Committee (CEUA) of the Aggeu Magalh\u00e3es Institute (protocol N\u00ba 149\/2019).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}}],"article-number":"116"}}